Capayosa, Gabriel .

HRN: 22-71-42  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/07/2026
08/13/2026
IVT
65mg
Q8H
PCAP B
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: